ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,071Medicare Part D Prescriptions Filled, Including Refills

Rank: 143 out of 625

$474K Total Retail Price of All Prescriptions

Rank: 196 out of 625

555 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 555 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 555 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 6,345 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
LEVOTHYROXINE SODIUM 424 289 1 3
AMLODIPINE BESYLATE 408 368 2 1
HYDROCODONE-ACETAMINOPHEN 376 211 S3 3 4
SIMVASTATIN 328 279 4 2
LISINOPRIL 248 154 5 5
OMEPRAZOLE 231 127 6 6
ATORVASTATIN CALCIUM 225 195 7 9
METOPROLOL TARTRATE 221 183 8 11
FUROSEMIDE 216 145 9 7
LOSARTAN POTASSIUM 194 171 10 18
METFORMIN HCL 176 121 11 10
HYDROCHLOROTHIAZIDE 165 142 12 12
POTASSIUM CHLORIDE 159 111 13 19
METOPROLOL SUCCINATE 150 112 14 15
LOVASTATIN 146 117 15 58
GLIMEPIRIDE 144 105 16 42
SERTRALINE HCL 126 97 17 26
CITALOPRAM HBR 120 61 18 24
FLUTICASONE PROPIONATE 106 58 19 32
ZOLPIDEM TARTRATE 104 37 20 13
PRAVASTATIN SODIUM 99 86 21 8
FENOFIBRATE 96 43 22 59
CRESTOR 95 52 23 17
TRAMADOL HCL 91 70 24 16
MELOXICAM 88 60 25 31
GABAPENTIN 84 36 26 14
WARFARIN SODIUM 83 67 27 20
ALENDRONATE SODIUM 81 67 28 34
NEXIUM 76 38 29 21
ALLOPURINOL 70 50 30 29
FLUOXETINE HCL 69 12 31 62
LOSARTAN-HYDROCHLOROTHIAZIDE 68 62 32 38
DIVALPROEX SODIUM 68 63 32 91
ATENOLOL 64 54 34 22
AMLODIPINE BESYLATE-BENAZEPRIL 58 36 35 48
PREDNISONE 55 40 36 37
CLOPIDOGREL 55 37 36 30
DIOVAN 54 51 38 28
PLAVIX 54 39 38 43
CARVEDILOL 53 25 40 23
KLOR-CON M20 52 40 41 47
CYMBALTA 50 15 42 46
LYRICA 50 30 42 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.